What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains

Author:

Jakubczyk MichałORCID

Abstract

AbstractPrioritizing health technologies requires comparisons of improvements in longevity or quality of life (QoL), or both. For this purpose, value sets are constructed that contain weights assigned to health states based on societal preferences. I show that how this is typically done may distort the results by giving unjustifiably larger impact to individuals who prioritize improvements in QoL over longevity. The problem results from equating the utility differences between being dead and full health across people, ignoring the fact that interpersonal utility comparisons are forbidden (or at least problematic) in economics. I propose another approach: the numerical value of maximal health gain (either in longevity or QoL) is assumed to be equal across individuals, to remove the impact of the range of utilities differing between people. I test this approach using EQ-5D-5L and EQ-5D-3L utilities elicited in Poland for two modeling techniques: a simple econometric model and a Bayesian one that accounts for censoring. The proposed approach increases the utilities of the worst health state: from $$-0.41$$ - 0.41 to $$-0.25$$ - 0.25 in EQ-5D-5L and from about $$-0.54$$ - 0.54 to $$-0.36$$ - 0.36 in EQ-5D-3L. In the Bayesian approach, the impact is greater: from $$-0.45$$ - 0.45 to $$-0.11$$ - 0.11 for EQ-5D-5L and from $$-0.54$$ - 0.54 to $$-0.22$$ - 0.22 for EQ-5D-3L. I discuss some normative arguments why the proposed approach may be more justifiable for aggregating individual preferences for health outcomes.

Funder

EuroQol Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Reference37 articles.

1. Rücker, G., Schumacher, M.: Simpson’s paradox visualized: The example of the Rosiglitazone meta-analysis. BMC Med. Res. Methodol. 8, 34 (2008)

2. MF Drummond, MJ Sculpher, K Claxton, GL Stoddart, and GW Torrance. Methods for the economic evaluation of health care programmes. Fourth Edition. Oxford University Press (2015)

3. MR Gold, JE Siegel, LB Russell, and MC Weinstein, editors. Cost-effectiveness in health and medicine. Oxford University Press (1996)

4. Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., Boye, K.S.: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur. J. Health Econ. 21, 1245–1257 (2020)

5. Torrance, G.W., Thomas, W.H., Sackett, D.L.: A utility maximization model for evaluation of health care programs. Health Serv. Res 7, 118–133 (1972)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3